Skip to main content
Clinical Trials/NCT06171737
NCT06171737
Enrolling by Invitation
N/A

PCORI-CDR-2022C1-26333 Promoting Shared Decision Making for Decisions About Treatment of Severe Aortic Stenosis (IMPACT SDM Study)

Massachusetts General Hospital8 sites in 1 country1,300 target enrollmentMarch 27, 2024
ConditionsAortic Stenosis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Aortic Stenosis
Sponsor
Massachusetts General Hospital
Enrollment
1300
Locations
8
Primary Endpoint
Shared Decision Making
Status
Enrolling by Invitation
Last Updated
10 months ago

Overview

Brief Summary

The goal of this study is to increase shared decision making for patients considering treatment for severe aortic stenosis. The main questions it aims to answer are:

  • Do patient decision aids and clinician skills training course improve the quality of decisions, and do they work well for different patient populations?
  • Are heart clinics able to reach the majority of patients with decision aids before their specialist visit and do the majority of clinicians complete the training course?

All participating sites will start in the usual care group and then will be randomly assigned a time to switch to the intervention group. Participants will complete surveys before and after their specialist visit.

Researchers will compare data from patients seen during usual care with data from those seen after the interventions are implemented to see if there are improvements in the quality of decisions.

Detailed Description

The goal of this study is to promote shared decision making for patients considering treatment for severe aortic stenosis. The main questions it aims to answer are: * Do patient decision aids and clinician skills training course improve the quality of decisions, and do they work well for different patient populations? * Are heart clinics able to reach the majority of patients with decision aids before their specialist visit and do the majority of clinicians complete the training course? This study is a batched stepped wedge cluster randomized trial with 8 sites, about 56 surgeons and interventional cardiologists, and will enroll about 1300 patients. All participating sites will start in the usual care group and then will be randomly assigned a time to switch to the intervention group. The interventions include a patient decision aid that was created by the American College of Cardiology CardioSmart program and a online shared decision making skills training course for clinicians. The coordinating center will provide implementation support to sites when they transition to the intervention arm. Data collection is similar across usual care and intervention groups. Patient participants will complete surveys before and after their specialist visit. Clinician participants will be randomly selected to complete a survey after the patient visit. Limited clinical data will be collected from the medical record. Researchers will compare data from patients seen during usual care with data from those seen after the interventions are implemented to see if there are improvements in the quality of decisions. Researchers will also calculate percentage of patients reached with decision aids and percentage of clinicians who complete training at each site to measure the success of the implementation.

Registry
clinicaltrials.gov
Start Date
March 27, 2024
End Date
October 31, 2027
Last Updated
10 months ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Karen Sepucha

Associate Professor

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • Between 65-85 years of age
  • Language is English or Spanish
  • Diagnosed with severe aortic stenosis defined as (e.g. an aortic valve area \< 1 cm2 or as determined by clinician)
  • Attend a scheduled visit with an Interventional Cardiologist and/or Cardiac Surgeon from the Heart Valve Team at a participating site

Exclusion Criteria

  • Prior aortic valve replacement surgery
  • High risk for either SAVR or TAVI (e.g., Society of Thoracic Surgery score \>8% or clinician determined)
  • Prior coronary artery bypass surgery (CABG)
  • End stage renal disease on dialysis
  • Severe lung disease (chronic obstructive pulmonary disease; COPD) requiring home oxygen
  • Advanced Cirrhosis
  • Unable to consent for self (proxy respondents are not allowed)

Outcomes

Primary Outcomes

Shared Decision Making

Time Frame: About 1 week post visit

Shared Decision Making Process scale; Scores range 0-4 with higher scores indicating greater shared decision making occurred.

Secondary Outcomes

  • Reach(About 1 week post visit)
  • Patient Knowledge(About 1 week post visit)
  • Preference-treatment concordance(About 1 week post visit)
  • Patient experience(About 1 week post visit)
  • Clinician satisfaction(About 1 week post visit)
  • Adoption(4 weeks from the start of intervention period for each site)
  • Timeliness (time to decision)(About 1 week post visit)
  • Timeliness (burden)(About 1 week post visit)

Study Sites (8)

Loading locations...

Similar Trials